Trial · NCT00006164
Trial comparisons12
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 12 of 12
Download this page as JSON| Comparison | Source |
|---|---|
| Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: Serious Adverse Events | Trial comparisons |
| Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: Development of Hepatocellular Carcinoma (HCC) | Trial comparisons |
| Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: Variceal Hemorrhage | Trial comparisons |
| Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: Increase in Ishak Fibrosis Score by 2 Points or More at 2 or 4 Year Biopsies | Trial comparisons |
| Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: Ascites | Trial comparisons |
| Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: Presumed Hepatocellular Carcinoma (HCC) | Trial comparisons |
| Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: Death From Any Cause | Trial comparisons |
| Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: Spontaneous Bacterial Peritonitis | Trial comparisons |
| Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: Child-Turcotte-Pugh (CTP) Score of 7 or Higher at Two Consecutive Study Visits | Trial comparisons |
| Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: Hepatic Encephalopathy | Trial comparisons |
Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: Progression of Liver Disease as Indicated by Death, Hepatic Decompensation, Hepatocellular Carcinoma, or for Patients With Noncirrhotic Fibrosis at Baseline, an Increase in the Ishak Hepatic Fibrosis Score of 2 or More Points | Trial comparisons |
| Peginterferon Alfa-2a 90 mcg/Week vs Standard of Care Followup: serious adverse events | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00006164/comparisons